SCHEMBL5656847

SCHEMBL5656847

CCOC(=O)/C(C)=C(/C)NC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
ALDH1A1 P00352 4/20 0.44
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GLO1 Q04760 1/20 0.42
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
SOAT1 P35610 1/20 0.41
EGLN1 Q9GZT9 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
PKM P14618 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3409989 1.00 MAPT (0.47) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL28036731 0.80 ALDH1A1 (0.44) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL20045209 0.79 MAPT (0.41) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL5611950 0.78 ALDH1A1 (0.58) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL5611940 0.78 ALDH1A1 (0.58) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL11141816 0.78 ALDH1A1 (0.58) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL9397981 0.77 MAPT (0.50) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL1132073 0.75 ALDH1A1 (0.39) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL11150815 0.75 ALDH1A1 (0.48) MAPTALDH1A1LMNAHSD17B10GLO1
SCHEMBL29134075 0.75 ALDH1A1 (0.48) MAPTALDH1A1LMNAHSD17B10GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7214813-B2 Preparation of chiral cyclic amino acids and derivatives THE PENN STATE RESEARCH FOUNDATION (US) 2007-05-08 US disclosed
US-7214813-B2 Preparation of chiral cyclic amino acids and derivatives THE PENN STATE RESEARCH FOUNDATION (US) 2007-05-08 US disclosed
US-20040242889-A1 Preparation of chiral cyclic amino acids and derivatives THE PENN STATE RESEARCH FOUNDATION 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242889-A1 Preparation of chiral cyclic amino acids and derivatives AADAT, PAM, BCAT2 MAPT 3985/4885ALDH1A1 2383/4885LMNA 4358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.